Infosys to acquire Denmark-based BASE life science for 110 mln euros

14 Jul 2022 , 11:26 AM

Headquartered in Denmark, BASE is one of the fastest growing technology and consulting partners in the life sciences industry. The company has about 200 of the finest, multidisciplinary industry experts across Denmark, Switzerland, UK, Germany, France, Italy, and a nearshore technology hub in Spain. Together with Infosys, BASE will further expand its portfolio of expertise into consumer health, animal health, medtech and genomics segments. BASE collaborates with leading software technology providers in the life sciences industry such as Veeva, IQVIA and Salesforce. Infosys will acquire 100% of the equity share capital in BASE life science for a cash consideration of upto Euro 110 million. It is including management incentives, bonuses and retention. The acquisition is expected to close during the second quarter of fiscal 2023, subject to customary closing conditions. BASE will bring to Infosys, domain experts with commercial, medical, digital marketing, clinical, regulatory, and quality knowhow. Backed by a team of data science specialists, BASE is at the frontier of the latest technological developments and trends. It has a strong focus on Data & AI, and the ability to bridge and integrate business logic and technology, driving insights for better health outcomes, Infosys said. BASE life science is an innovative and forward-thinking technology, product and service consultancy specialized in creating real business value from digital platforms and data, growing people, and delivering innovative solutions that have a sustainable and lasting impact in an industry that matters. BASE life science reported revenue of 26.6 million euros during the fiscal year ended 30 June 2022. Ravi Kumar S, President of Infosys, said, This acquisition augments Infosys deep life sciences expertise, and expands our footprint further in the Nordics region and across Europe, and scales our digital transformation capabilities with cloud-based industry solutions. We are excited to welcome BASE life science and its leadership team into the Infosys family. Martin Woergaard, CEO at BASE life science commented, Over the last five years, BASE life science has delivered tremendous growth, and created a stellar life sciences consulting firm in Europe. With Infosys as our catalyst, we will be able to accelerate our expansion internationally and create development opportunities for our people. Infosys is a solid, global technology leader that is a perfect match for ensuring continuous success of BASE while sharing our common purpose and values. Infosys is a global leader in digital services and consulting. The companys consolidated net profit fell 2.1% to Rs 5,686 crore on a 1.3% increase in revenues to Rs 32,276 crore in Q4 FY22 over Q3 FY22. Shares of Infosys were up 0.21% to Rs 1,447.95 on the BSE. Powered by Capital Market – Live News